ArticleFrontiers in medicine2021

Delayed Infliximab Treatment Affects the Outcomes of Patients With Crohn's Disease During the COVID-19 Epidemic in China: A Propensity Score-Matched Analysis.

Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.